Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001597:Benzylidene Compounds / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004347:Drug Interactions; D006801:Humans; D007192:Indenes / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D007408:Intestinal Absorption; D007592:Joint Diseases / Q000188:drug therapy; D007700:Kinetics; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014018:Tissue Distribution
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001597:Benzylidene Compounds; D007192:Indenes